We thus investigated a possible role for G6PC2 variants in modulating the susceptibility to T2D in subjects from Saudi Arabia, a region with a high prevalence of metabolic disorders, including T2D [43, 44]. The gene discussed is G6PC2; the disease is metabolic disease.